Shortage reports
Actual shortage:
35 (1%)
Anticipated shortage:
9 (0%)
Avoided shortage:
19 (1%)
Resolved:
2320 (97%)
2383
Discontinuation Reports
To be discontinued:
3 (2%)
Discontinued:
131 (96%)
Reversed:
2 (1%)
136
466 (18%)
3 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2022-04-06 | 2022-09-28 | 158050 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2020-10-22 | 2020-11-28 | 126961 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2022-11-28 | 2023-01-19 | 176073 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2017-07-11 | 2017-08-02 | 15469 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2022-02-08 | 2022-02-25 | 154511 |
| VERAPAMIL HYDROCHLORIDE INJECTION USP | 2.5MG | LIQUID | Resolved | 2022-11-28 | 2023-01-19 | 175970 |
| VERAPAMIL HYDROCHLORIDE INJECTION USP | 2.5MG | LIQUID | Resolved | 2023-11-06 | 2024-01-03 | 209230 |
| VERAPAMIL HYDROCHLORIDE INJECTION USP | 2.5MG | LIQUID | Resolved | 2023-07-10 | 2023-08-01 | 198005 |
| VERAPAMIL HYDROCHLORIDE INJECTION USP | 2.5MG | LIQUID | Resolved | 2023-03-03 | 2023-04-22 | 186176 |
| VISTITAN | 0.03% | SOLUTION | Resolved | 2021-09-13 | 2021-10-04 | 145576 |
| VISTITAN | 0.03% | SOLUTION | Resolved | 2023-04-11 | 2023-04-22 | 189229 |
| VISTITAN | 0.03% | SOLUTION | Resolved | 2022-06-29 | 2022-07-07 | 163618 |
| VISTITAN | 0.03% | SOLUTION | Resolved | 2022-02-01 | 2022-03-25 | 154002 |
| VISTITAN | 0.03% | SOLUTION | Resolved | 2024-09-30 | 2024-10-15 | 238948 |
| VISTITAN | 0.03% | SOLUTION | Anticipated shortage | 2026-04-20 | 2026-04-20 | 283193 |
| VISTITAN | 0.03% | SOLUTION | Resolved | 2024-03-05 | 2024-06-26 | 221377 |
| VITAMIN B1 | 100MG | SOLUTION | Resolved | 2024-02-15 | 2024-07-29 | 219763 |
| VITAMIN B12 | 1000MCG | SOLUTION | Resolved | 2025-09-15 | 2025-10-27 | 267133 |
| VITAMIN B12 | 1000MCG | SOLUTION | Resolved | 2023-03-06 | 2023-04-05 | 186307 |
| VITAMIN B12 | 1000MCG | SOLUTION | Resolved | 2024-09-30 | 2024-11-13 | 238955 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ RANITIDINE | 150MG | TABLET | Reversed | 2020-06-17 | 2020-06-17 | 118175 |
| SANDOZ RISPERIDONE | 0.5MG | TABLET | Discontinued | 2025-12-01 | 2025-12-02 | 272923 |
| SANDOZ RISPERIDONE | 3MG | TABLET | Discontinued | 2026-04-15 | 2026-04-15 | 282885 |
| SANDOZ RISPERIDONE | 2MG | TABLET | Discontinued | 2026-04-15 | 2026-04-15 | 282907 |
| SANDOZ RISPERIDONE | 2MG | TABLET | Discontinued | 2026-04-15 | 2026-04-15 | 282904 |
| SANDOZ RISPERIDONE | 1MG | TABLET | Discontinued | 2026-04-15 | 2026-04-15 | 282901 |
| SANDOZ RISPERIDONE | 3MG | TABLET | Discontinued | 2026-04-15 | 2026-04-15 | 282882 |
| SANDOZ RISPERIDONE | 3.0MG | TABLET | Discontinued | 2021-03-22 | 2021-03-22 | 136095 |
| SANDOZ RISPERIDONE | 1.0MG | TABLET | Discontinued | 2021-08-19 | 2021-08-19 | 144338 |
| SANDOZ RISPERIDONE | 1MG | TABLET | Discontinued | 2025-07-02 | 2025-07-03 | 261506 |
| SANDOZ RISPERIDONE | 0.25MG | TABLET | Discontinued | 2026-04-15 | 2026-04-15 | 282898 |
| SANDOZ RISPERIDONE | 4MG | TABLET | Discontinued | 2026-04-15 | 2026-04-15 | 282918 |
| SANDOZ RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2025-06-25 | 2025-06-26 | 261105 |
| SANDOZ RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2024-12-10 | 2024-12-11 | 245291 |
| SANDOZ RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2024-12-10 | 2024-12-11 | 245288 |
| SANDOZ RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2024-12-10 | 2024-12-11 | 245285 |
| SANDOZ RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2024-12-10 | 2024-12-11 | 245282 |
| SANDOZ RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2024-12-10 | 2024-12-11 | 245279 |
| SANDOZ RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2024-12-10 | 2024-12-11 | 245276 |
| SANDOZ RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2024-12-10 | 2024-12-11 | 245273 |